rs3744825

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015559.3(SETBP1):​c.3301G>A​(p.Val1101Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.127 in 1,613,728 control chromosomes in the GnomAD database, including 14,285 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1124 hom., cov: 32)
Exomes 𝑓: 0.13 ( 13161 hom. )

Consequence

SETBP1
NM_015559.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.23

Publications

41 publications found
Variant links:
Genes affected
SETBP1 (HGNC:15573): (SET binding protein 1) This gene encodes a protein which contains a several motifs including a ski homology region and a SET-binding region in addition to three nuclear localization signals. The encoded protein has been shown to bind the SET nuclear oncogene which is involved in DNA replication. Mutations in this gene are associated with Schinzel-Giedion midface retraction syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
SETBP1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability, autosomal dominant 29
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Schinzel-Giedion syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • intellectual disability-expressive aphasia-facial dysmorphism syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004114777).
BP6
Variant 18-44952641-G-A is Benign according to our data. Variant chr18-44952641-G-A is described in ClinVar as Benign. ClinVar VariationId is 159872.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.268 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SETBP1NM_015559.3 linkc.3301G>A p.Val1101Ile missense_variant Exon 4 of 6 ENST00000649279.2 NP_056374.2 Q9Y6X0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SETBP1ENST00000649279.2 linkc.3301G>A p.Val1101Ile missense_variant Exon 4 of 6 NM_015559.3 ENSP00000497406.1 Q9Y6X0-1

Frequencies

GnomAD3 genomes
AF:
0.107
AC:
16311
AN:
151918
Hom.:
1125
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0504
Gnomad AMI
AF:
0.245
Gnomad AMR
AF:
0.0864
Gnomad ASJ
AF:
0.137
Gnomad EAS
AF:
0.281
Gnomad SAS
AF:
0.0949
Gnomad FIN
AF:
0.142
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.125
Gnomad OTH
AF:
0.119
GnomAD2 exomes
AF:
0.123
AC:
30826
AN:
250638
AF XY:
0.123
show subpopulations
Gnomad AFR exome
AF:
0.0502
Gnomad AMR exome
AF:
0.0822
Gnomad ASJ exome
AF:
0.141
Gnomad EAS exome
AF:
0.281
Gnomad FIN exome
AF:
0.140
Gnomad NFE exome
AF:
0.126
Gnomad OTH exome
AF:
0.124
GnomAD4 exome
AF:
0.129
AC:
187844
AN:
1461690
Hom.:
13161
Cov.:
49
AF XY:
0.127
AC XY:
92524
AN XY:
727100
show subpopulations
African (AFR)
AF:
0.0479
AC:
1603
AN:
33478
American (AMR)
AF:
0.0824
AC:
3684
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.140
AC:
3649
AN:
26132
East Asian (EAS)
AF:
0.310
AC:
12320
AN:
39694
South Asian (SAS)
AF:
0.0836
AC:
7210
AN:
86256
European-Finnish (FIN)
AF:
0.135
AC:
7197
AN:
53420
Middle Eastern (MID)
AF:
0.0969
AC:
559
AN:
5766
European-Non Finnish (NFE)
AF:
0.129
AC:
143717
AN:
1111834
Other (OTH)
AF:
0.131
AC:
7905
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
10276
20553
30829
41106
51382
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5262
10524
15786
21048
26310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.107
AC:
16305
AN:
152038
Hom.:
1124
Cov.:
32
AF XY:
0.108
AC XY:
8006
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.0503
AC:
2087
AN:
41500
American (AMR)
AF:
0.0862
AC:
1317
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.137
AC:
475
AN:
3470
East Asian (EAS)
AF:
0.280
AC:
1443
AN:
5150
South Asian (SAS)
AF:
0.0950
AC:
457
AN:
4812
European-Finnish (FIN)
AF:
0.142
AC:
1494
AN:
10544
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.125
AC:
8525
AN:
67980
Other (OTH)
AF:
0.120
AC:
252
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
714
1428
2143
2857
3571
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
188
376
564
752
940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.122
Hom.:
4218
Bravo
AF:
0.104
TwinsUK
AF:
0.127
AC:
470
ALSPAC
AF:
0.139
AC:
536
ESP6500AA
AF:
0.0572
AC:
252
ESP6500EA
AF:
0.125
AC:
1072
ExAC
AF:
0.121
AC:
14714
Asia WGS
AF:
0.176
AC:
610
AN:
3478
EpiCase
AF:
0.127
EpiControl
AF:
0.129

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Schinzel-Giedion syndrome Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
10
DANN
Benign
0.87
DEOGEN2
Benign
0.20
T;T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.69
FATHMM_MKL
Benign
0.46
N
LIST_S2
Benign
0.71
.;T
MetaRNN
Benign
0.0041
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N;N
PhyloP100
1.2
PrimateAI
Benign
0.30
T
PROVEAN
Benign
0.39
.;N
REVEL
Benign
0.033
Sift
Benign
0.14
.;T
Sift4G
Benign
0.22
.;T
Polyphen
0.052
B;B
Vest4
0.095
MPC
0.22
ClinPred
0.0021
T
GERP RS
-0.53
Varity_R
0.027
gMVP
0.083
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3744825; hg19: chr18-42532606; COSMIC: COSV56312865; API